There is a good news today among the increasing cases of Corona virus in the country. From today, the third and last phase trial of the first indigenous corona vaccine will be started in the country. On Tuesday, the Union Ministry of Health and the Indian Council of Medical Research (ICMR) held a press conference. The press conference was attended by Rajesh Bhushan, Secretary, Ministry of Health, Dr. VK Paul, member of NITI Aayog and Dr. Balram Bhargava, Director General of ICMR, during which he gave many information about the condition of corona vaccine in the country.
During this press conference, Dr. Paul, Member, NITI Aayog, said that three corona vaccines are currently in operation in the country. All these vaccines are in different stages of trial. He had informed that the third and last phase of trial of one of these three vaccines will start from today (Wednesday). However, he did not reveal the name of the vaccine. He informed that the trial of the other two vaccines in the country is in its first and second phase.
On August 15, Prime Minister Narendra Modi mentioned the testing of three corona vaccines in the country from Red Fort. He told that the trials of all these vaccines are being done in different stages. Trial of three vaccines – Bharat Biotech – ICMR’s Covaxin, Zydus Cadila’s Zykov-D and Oxford-AstraZeneca’s Covishield by Serum India is currently under various stages of testing in the country.
First vaccine – Kovaxin
Kovaxin, the country’s first indigenous Kovid-19 vaccine, has been launched by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) for human trials.
Second Vaccine – Zaykov-D
The Ahmedabad-based pharmaceutical company Zydus Cadila Vaccine Zykov-D is also undergoing a human clinical trial. The company says that the vaccine may be launched by next year.
Third Vaccine – Kovishield
The Pune-based Serum Institute of India has obtained permission from the Drug Controller General of India to begin trials in India for the vaccine developed by Oxford University and Astra Janeca. The name of this vaccine is Covishield.